Trial Profile
Investigation of efficacy and safety of botulinum toxin A (Botox-Allergan Inc) in migraine headaches.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 11 Mar 2016 Protocol amended as study design changed from single to parallel group assignment as reported by ClinicalTrials.gov.
- 11 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Aug 2011 Planned end date changed from 1 Dec 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.